INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
52 hedge funds and large institutions have $203M invested in Inozyme Pharma in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
10.35% less ownership
Funds ownership: 84.25% → 73.9% (-10%)
40% less capital invested
Capital invested by funds: $337M → $203M (-$134M)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.2M | |
| 2 | +$3.72M | |
| 3 | +$3.65M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.08M |
Top Sellers
| 1 | -$34.1M | |
| 2 | -$31.8M | |
| 3 | -$4.23M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$888K |
| 5 |
Millennium Management
New York
|
-$581K |